Related Experiment Video

Updated: Jun 10, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

New views on natural killer cell-based immunotherapy for melanoma treatment

Shannon Burke1, Tadepally Lakshmikanth, Francesco Colucci

  • 1Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.

Trends in Immunology
|July 27, 2010
PubMed

Insights

Natural killer (NK) cell immunotherapies show promise for treating melanoma. Combining NK cell therapy with other treatments may improve outcomes for solid tumors like melanoma.

Area of Science:

  • Immunology
  • Oncology
  • Cancer immunotherapy

Background:

  • Natural killer (NK) cell immunotherapies are effective against blood cancers but less so against solid tumors.
  • Melanoma progression presents unique challenges for NK cell recognition and efficacy.
  • A combinatorial approach is needed to maximize NK cell potential in treating melanoma.

Purpose of the Study:

  • To review current understanding of NK cell interactions with melanoma at different disease stages.
  • To propose a multifaceted strategy for enhancing NK cell-based melanoma immunotherapy.
  • To explore combinations of NK cell therapy with pharmacological and T cell-based approaches.

Main Methods:

  • Review of recent scientific literature on NK cell recognition in melanoma.
  • Analysis of melanoma progression stages and their impact on NK cell activity.
  • Proposal of combinatorial immunotherapy strategies tailored to disease stage.

Main Results:

  • NK cell activity and recognition vary significantly with melanoma progression.
  • Combinatorial strategies can address specific challenges at different stages of melanoma.
  • Potential applications include preventing lymph node metastasis, boosting NK cell activity, and targeting visceral metastasis.

Conclusions:

  • NK cell immunotherapy holds potential for melanoma treatment when combined strategically.
  • Pharmacological and T cell-based therapies can synergize with NK cells to overcome solid tumor limitations.
  • Tailored combinatorial approaches are crucial for effective NK cell-based melanoma treatment.

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...